Hospitals & health systems
Build clinically characterised microbiome programmes with VAMS BIOME.
VAMS BIOME combines microbiome testing infrastructure with VAMS ATLAS™ structured intelligence to support appropriately governed clinical research, cohort development and longitudinal programmes with hospital partners.
The opportunity is bigger than adding another microbiome test.
Hospital collaboration can potentially support:
- Clinically characterised cohorts
- Prospective research programmes
- Longitudinal microbiome measurement
- Specialist-reviewed workflows
- Microbiome and phenotype research
- Regional and reference cohort development
- Appropriate future clinical-service evaluation
These are research and collaboration directions. Clinical utility is not established in advance of evaluation, and nothing here describes a validated clinical service.
Complementary capabilities
Neither half answers the question alone.
VAMS BIOME™
- Collection and testing infrastructure
- Multi-ecosystem pathways
- Participant and report workflows
- Longitudinal measurement
VAMS ATLAS™
- Scores, panels and Insight Packs
- Confidence context
- Evidence provenance
- Reference and cohort comparison
- Structured reporting
Hospital partner
- Clinical expertise
- Clinical phenotype
- Specialist-defined cohorts
- Research governance
- Interventions and context
- Longitudinal outcomes
Jointly evaluated microbiome research & precision-health programmes
Microbiome interpretation depends on context.
Geography, diet, medication, age, life stage and clinical phenotype can all affect microbiome composition, so the choice of comparison group is itself a scientific decision.
- Global research Published and curated population data
- India Country-level reference context
- Regional populations Diet, geography and life-stage variation
- Clinically characterised cohorts Phenotype-linked — requires a hospital partner
- Individual context Read as population context, never as a verdict
VAMS is building governed cohort infrastructure. VAMS does not claim a clinically validated, representative Indian reference population; hospital partnerships create the opportunity to develop prospective, deeply characterised regional cohorts.
Start with a defined question, not a large commitment.
- 1Discovery
- 2Scientific question
- 3Cohort design
- 4Governance & ethics
- 5Sample & data workflow
- 6ATLAS analysis
- 7Clinical & research review
- 8Evaluation
- 9Scale decision
Potential areas for discussion
- Gastrointestinal research
- Inflammatory bowel disease research
- Metabolically characterised populations
- Liver and metabolic research
- Healthy and reference populations
- Longitudinal microbiome programmes
Illustrative pilot scale; final cohort design and sample size depend on the research question and its statistical requirements. These are research and collaboration examples, not diagnostic indications.
Partnership models
Clinical research collaboration
A jointly scoped research programme built around a defined question.
Cohort development
Prospective, clinically characterised microbiome cohorts.
Institutional microbiome programme
A defined hospital workflow supported by VAMS infrastructure.
ATLAS / reporting infrastructure
Structured microbiome intelligence for appropriately governed workflows.
Longitudinal programme
Repeat measurement with structured longitudinal comparison.
Strategic collaboration
Research, technology and co-development discussions.
Have a clinical or research question in mind?
Tell us what population, programme or research question you are exploring. We can assess method fit, cohort requirements, governance and the appropriate next step.
Thank you. Your enquiry has been received.
Our team will review your organisation, goals and requested pathway, and route the enquiry to the appropriate VAMS team.